RIVERNORTH CAPITAL MANAGEMENT, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 41 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RIVERNORTH CAPITAL MANAGEMENT, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$1,760,072
+1.6%
172,0500.0%0.08%
+9.0%
Q4 2022$1,732,544
+2.2%
172,0500.0%0.08%
+2.6%
Q3 2022$1,696,000
+1.2%
172,0500.0%0.08%
+11.8%
Q2 2022$1,676,000
-0.2%
172,0500.0%0.07%
+7.9%
Q1 2022$1,679,000
-1.7%
172,050
-1.7%
0.06%
-8.7%
Q4 2021$1,708,000
-0.2%
174,9850.0%0.07%
-24.2%
Q3 2021$1,711,000174,9850.09%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,199,000$11,672,0000.82%
MMCAP International Inc. SPC 800,000$7,788,0000.62%
Arena Capital Advisors, LLC- CA 250,917$2,443,0000.62%
Atalaya Capital Management LP 500,000$4,870,0000.58%
DG Capital Management, LLC 127,665$1,243,0000.45%
Kepos Capital LP 500,000$4,868,0000.44%
KIM, LLC 800,000$7,792,0000.37%
ANGELO GORDON & CO., L.P. 300,000$2,921,0000.32%
FIR TREE CAPITAL MANAGEMENT LP 950,803$9,261,0000.29%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$4,868,0000.28%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders